(RTTNews) - Medical technologies firm Teleflex Inc. (TFX) announced Thursday that its UroLift System for treating benign prostatic hyperplasia or BPH has received regulatory clearance in China. The ...
Teleflex (NYSE:TFX) reported new research from controlled and real-world studies of Prostatic Urethral Lift (PUL) procedure with its UroLift System to treat men with benign prostatic hyperplasia (BPH) ...
WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX) (NYSE:TFX), a leading global provider of medical technologies, announced today that a new peer-reviewed study in the Nature ...
Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...
NeoTract, Inc., today announced that the UK’s National Institute for Health and Clinical Excellence (NICE) has issued an interventional Procedure Guidance (IPG) approving the UroLift® prostatic lift ...
UroLift is a minimally invasive treatment option for benign prostatic hyperplasia (BPH), also called enlarged prostate. Medicare covers the UroLift procedure when a doctor deems it medically necessary ...
DEAR DR. ROACH: I’m 79, and for several years, I have been taking finasteride and tamsulosin for benign prostatic hyperplasia. (In the past, I underwent a TURP procedure, which I will never go through ...
TEXARKANA, Texas — Benign prostatic hyperplasia — or BPH — is a common condition in men over 50 that causes the prostate to enlarge. The enlarged prostate pinches the urethra, which carries urine from ...
In a ground-breaking medical achievement, Nigeria has become the first country in West and Central Africa to successfully perform the UroLift procedure, a revolutionary treatment for benign prostate ...
DEAR DR. ROACH: I’m 79, and for several years, I have been taking finasteride and tamsulosin for benign prostatic hyperplasia. (In the past, I underwent a TURP procedure, which I will never go through ...
Urolift is a minimally invasive procedure to help treat an enlarged prostate, known as benign prostatic hyperplasia (BPH). Medicare will typically cover Urolift procedures when a doctor deems them ...
This guidance updates and replaces NICE’s medical technologies guidance on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26). Medical technologies guidance 58 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results